Black women with chronic myeloid leukemia face unique challenges when it comes to diagnosis, treatment, and overall disease ...
A little girl was diagnosed with a rare form of cancer after her parents noticed unexplained bruising. At just age four, Esha ...
Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...
Early measurable residual disease clearance is linked to better outcomes in acute myeloid leukemia, study suggests.
Clinical Trials Arena on MSN5d
Cantargia enrols first patient in trial of nadunolimab for AML and MDSSwedish company Cantargia has enrolled the first patient in the Phase Ib/IIa trial of nadunolimab for treating individuals ...
In March 2025, Akeso initiated an open-label, Phase Ib/II study involving patients diagnosed with acute myeloid leukemia (AML ...
Triplet Regimen Yields Promising Response in Advanced-Phase Chronic Myeloid Leukemia Sep. 17, 2024 — According to new research, 80% of patients with previously untreated or relapsed/refractory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback